1-[2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoyl]pyrrolidine-2-carboxylic acid | CAS:103300-89-6

We serve 1-[2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoyl]pyrrolidine-2-carboxylic acid CAS:103300-89-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-[2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoyl]pyrrolidine-2-carboxylic acid

Chemical Name:1-[2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoyl]pyrrolidine-2-carboxylic acid
CAS.NO:103300-89-6
Synonyms:1-[2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoyl]pyrrolidine-2-carboxylic acid
1-[2-azanyl-6-[2,2,2-tris(fluoranyl)ethanoylamino]hexanoyl]pyrrolidine-2-carboxylic acid
N6-trifluoroacetyl-L-lysyl-L-proline
N|A-Trifluoroacetyl-Lys-Pro
L-Proline,N6-(2,2,2-trifluoroacetyl)-L-lysyl
1-[2-amino-1-oxo-6-[(2,2,2-trifluoro-1-oxoethyl)amino]hexyl]-2-pyrrolidinecarboxylic acid
 
Physical and Chemical Properties:
Density 1.364 g/cm3
Boiling Point 550.929ºC at 760 mmHg
Molecular Formula C13H20F3N3O4
Molecular Weight 339.31100
Flash Point 286.992ºC
Vapour Pressure 1.37E-13mmHg at 25°C
Index of Refraction 1.496
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lisinopril(CAS:76547-98-3).



Contact us for information like 1-[2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoyl]pyrrolidine-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-[2-amino-1-oxo-6-[(2,2,2-trifluoro-1-oxoethyl)amino]hexyl]-2-pyrrolidinecarboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[2-amino-1-oxo-6-[(2,2,2-trifluoro-1-oxoethyl)amino]hexyl]-2-pyrrolidinecarboxylic acid Use and application,L-Proline,N6-(2,2,2-trifluoroacetyl)-L-lysyl technical grade,usp/ep/jp grade.


Related News: In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.1,1-diethylguanidine,hydrochloride manufacturer Professor Coleman was involved in some of the first research into MERS in the US.4-(4-bromophenyl)-N,N-diphenylaniline supplier In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.[3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl methanesulfonate vendor The United Kingdom, for instance, is now warning against all but essential travel to mainland China, and is advising against all travel to Hubei province, where the outbreak was first reported.These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.